期刊文献+

缬沙坦与阿托伐他汀联合治疗对高血压病人颈动脉内膜中层厚度的影响 被引量:1

EFFECT OF VALSARTA AND ATORVASTATIN ON INTIMA-MEDIA THICKNESS OF COMMON CAROTID ARTERY IN PATIENTS WITH HYPERTENSION
下载PDF
导出
摘要 ①目的比较观察缬沙坦联合阿托伐他汀应用与单用对原发性高血压病人颈动脉内膜中层厚度(IMT)的影响及临床意义.②方法选择86例Ⅰ、Ⅱ级高血压且血脂正常病人,随机分为两组,A组应用缬沙坦80 mg,每日1次;B组应用缬沙坦80 mg,每日1次,并阿托伐他汀10 mg,每日1次,治疗12周.治疗前、后超声测定IMT、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白-C(LDL-C).③结果治疗2周后血压已显著下降(t=11.10~24.00,P<0.01),12周后血压趋于稳定,两组的降压幅度无显著差别(t=0.35~1.34,P>0.05).与治疗前比较,A组IMT有显著降低(t=2.04、2.65,P<0.05),TC、TG、LDL-C无显著改变(t=0.20~0.64,P>0.05),B组TC、TG、LDL-C、IMT均显著降低(t=2.83~14.10,P<0.01),两组比较有显著差异(t=2.53~7.34,P<0.05).④结论缬沙坦联合阿托伐他汀应用与单用比较,对逆转原发性高血压病人颈动脉IMT的效果显著. Objective To study the effects of valsarta combined with atorvastatin on intima-media thickness(IMT)of common carotid artery of patients with mild to moderate essential hypertension. Methods Eighty-six patients with mild to moderate essential hypertension and normal lipidemia were randomly divided into two groups. Group A was given Valsarta 80 mg qd;Group B, Valsarta 80 mg qd combined with atorvastatin 10 mg qd. Both were treated for 12 weeks. IMT, TC, TG,LDL-C were evaluated before and after the treatment. Results There was no difference in BP, TC, TG, LDL-C or IMT between the two groups before treatment. BP decreased significantly (t=11.10-24.00, P〈0.01)two weeks after administration and decrease till the end of experiment in both groups. TC, TG, LDL-C, IMT were decreased significantly(t=2.83-14. 10, P〈0.01) in Group B and IMT were decreased significantly (t=2.04,2.65; P〈0.01) in Group A after 12 weeks. The difference was significant between the two groups (t=2.53-7.34, P〈0.05). Conclusion Valsarta combined with atorvastatin is more effective than Valsarta alone in IMT of the common carotid artery in the treatment of patients with mild to moderate hypertension.
出处 《青岛大学医学院学报》 CAS 2005年第2期132-133,136,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 缬沙坦 阿托伐他汀 颈动脉 IMT 高血压 valsarta atorvastatin carotid artery IMT hypertension
  • 相关文献

参考文献7

  • 1中国高血压防治指南起草委员会.中国高血压防治指南(1999年10月)[J].高血压杂志,2000,8(1):99-99.
  • 2方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 3童传凤,王瑞英,任江华.缬沙坦与卡托普利抑制动脉损伤后内膜增生作用的比较[J].中华心血管病杂志,2002,30(2):117-118. 被引量:18
  • 4Stanton AV, Chapman JN, Mayet J, et al. Effects of blood pressure lowering with amlodipine or lisinopril onvascular structure of the common coritid artery[J]. Clin Sci, 2001,101:455.
  • 5Alfon J, Guasch JF, Berrozpe M, et al. Nitric oxide synthase Ⅱ (NOS Ⅱ ) gene expression cor-relates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors[J]. Atherosclerosis,1999,145(2) :325.
  • 6Gotto FM. Lipid-lowering therapy for the primary prevention of coronary heart disease[J]. J Am Coll Cardiol, 1999,33:2078.
  • 7Knapp AC, Huang J, Starling G,et al. Inhibitors of HMGCoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death [J]. Atherosclerosis,2000,152:217.

共引文献3089

同被引文献5

  • 1POLLANEN P J,LEHTIMAKI T,MIKKELSSON J,et al.Matrix metalloproteinase 3 and 9 gene promoter polymorphisms:joint action of two loci as a risk factor for coronary artery complicated plaques[J].Atherosclerosis,2005,180(1):73-78.
  • 2ZENG B,PRASAN A,FUNG K C,et al.Elevated circula-ting levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease[J].Intern Med J,2005,35(6):331-335.
  • 3SUGIYAMA S,OKADA Y,SHUHOVA C K,et al.Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes[J].Am J Pathol,2001,158:879-891.
  • 4FERRY G,LONCHAMPT M,PENNEL L,et al.Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury[J].FEBS Lett,1997,402:111-115.
  • 5于辛,邵晓光,谭兰,罗兵.载脂蛋白E基因多态性与脑梗死的关系[J].青岛大学医学院学报,2000,36(4):265-267. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部